MedPath

Schistosomiasis in Women of Reproductive Age in Burkina Faso: Implications for Control

Completed
Conditions
Anaemia
Pregnancy
Schistosomiasis
Registration Number
NCT00463632
Lead Sponsor
DBL -Institute for Health Research and Development
Brief Summary

Cross-sectional study of prevalence and intensity of schistosome infection in pregnant women, follow-up into postpartum, and the association of schistosome infection with haemoglobin concentration, compared to a group of non-pregnant women.

Detailed Description

The objective of this study is to investigate the epidemiology of schistosomiasis and anaemia among pregnant and non-pregnant women in Burkina Faso and explore the implications for the national schistosomiasis control programme and future studies.

Specific objectives are:

* to determine the prevalence and intensity of schistosome infection in pregnant women attending for antenatal care and in non-pregnant women of reproductive age in an area which is hyperendemic for S.haematobium infection and in which there is little or no S.mansoni infection

* to determine the prevalence and intensity of schistosome infection in pregnant women attending for antenatal care and in non-pregnant women of reproductive age in an area in which S.mansoni infection is common

* to determine Haemoglobin concentration in pregnant women attending for antenatal care and in non-pregnant women of reproductive age in the regions described above

* to investigate the association between infection and haemoglobin concentration in pregnant and non-pregnant women

* to determine the prevalence of other parasitic infections in pregnant women and non-pregnant women including hookworms, ascaris, trichuris and malaria

* to demonstrate the research team's ability to follow-up pregnant women recruited at antenatal care clinics onto the postpartum period

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • Pregnant women attending for ANC
  • Non-pregnant women age 15-45 years accompanying relatives or children to the health centres or for immunization
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

National Schistosomiasis Control Program

🇧🇫

Ouagadougou, Burkina Faso

Dori Health Centre

🇧🇫

Dori, Burkina Faso

© Copyright 2025. All Rights Reserved by MedPath